BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27718511)

  • 21. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
    Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
    World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.
    Crouzet L; Gaultier E; Del'Homme C; Cartier C; Delmas E; Dapoigny M; Fioramonti J; Bernalier-Donadille A
    Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abolishment of TNBS-induced visceral hypersensitivity in mast cell deficient rats.
    Ohashi K; Sato Y; Kawai M; Kurebayashi Y
    Life Sci; 2008 Feb; 82(7-8):419-23. PubMed ID: 18222490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of the Lactobacillus rhamnosus Lcr35® properties after compression and proposition of a model to predict tablet stability.
    Muller C; Mazel V; Dausset C; Busignies V; Bornes S; Nivoliez A; Tchoreloff P
    Eur J Pharm Biopharm; 2014 Nov; 88(3):787-94. PubMed ID: 25128853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
    Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The multicomponent medication Spascupreel attenuates stress-induced gut dysfunction in rats.
    Theodorou V; Beaufrand C; Yvon S; Laforge G; Burmeister Y; Müller A; Seilheimer B; Bueno L; Eutamene H
    Neurogastroenterol Motil; 2020 May; 32(5):e13798. PubMed ID: 32059072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction.
    Ait-Belgnaoui A; Han W; Lamine F; Eutamene H; Fioramonti J; Bueno L; Theodorou V
    Gut; 2006 Aug; 55(8):1090-4. PubMed ID: 16507583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function.
    Dai C; Guandalini S; Zhao DH; Jiang M
    Mol Cell Biochem; 2012 Mar; 362(1-2):43-53. PubMed ID: 22020749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of
    Cao YN; Feng LJ; Liu YY; Jiang K; Zhang MJ; Gu YX; Wang BM; Gao J; Wang ZL; Wang YM
    World J Gastroenterol; 2018 Jan; 24(3):338-350. PubMed ID: 29391756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of Probiotic VSL#3 in a Rat Model of Visceral Hypersensitivity Involves the Mast Cell-PAR2-TRPV1 Pathway.
    Li YJ; Dai C; Jiang M
    Dig Dis Sci; 2019 May; 64(5):1182-1192. PubMed ID: 30560330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence from comparative genomic analyses indicating that
    Liu Y; Xiao W; Yu L; Tian F; Wang G; Lu W; Narbad A; Chen W; Zhai Q
    Food Funct; 2021 Feb; 12(3):1121-1134. PubMed ID: 33427835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats.
    Zhang J; Song L; Wang Y; Liu C; Zhang L; Zhu S; Liu S; Duan L
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1368-1376. PubMed ID: 30402954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oridonin Alleviates Visceral Hyperalgesia in a Rat Model of Postinflammatory Irritable Bowel Syndrome: Role of Colonic Enterochromaffin Cell and Serotonin Availability.
    Zang KH; Shao YY; Zuo X; Rao Z; Qin HY
    J Med Food; 2016 Jun; 19(6):586-92. PubMed ID: 27111743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome.
    Distrutti E; Cipriani S; Mencarelli A; Renga B; Fiorucci S
    PLoS One; 2013; 8(5):e63893. PubMed ID: 23691109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotic Yeast from Miso Ameliorates Stress-Induced Visceral Hypersensitivity by Modulating the Gut Microbiota in a Rat Model of Irritable Bowel Syndrome.
    Sugihara N; Okada Y; Tomioka A; Ito S; Tanemoto R; Nishii S; Mizoguchi A; Inaba K; Hanawa Y; Horiuchi K; Wada A; Akita Y; Higashiyama M; Kurihara C; Komoto S; Tomita K; Hokari R
    Gut Liver; 2024 May; 18(3):465-475. PubMed ID: 37291901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.
    Buckley MM; O'Halloran KD; Rae MG; Dinan TG; O'Malley D
    J Physiol; 2014 Dec; 592(23):5235-50. PubMed ID: 25260633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.
    Pedersen N; Andersen NN; Végh Z; Jensen L; Ankersen DV; Felding M; Simonsen MH; Burisch J; Munkholm P
    World J Gastroenterol; 2014 Nov; 20(43):16215-26. PubMed ID: 25473176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.